OmniComm Penetrates Growing Israeli Life Sciences Market


TrialMaster® EDC selected by leading Israeli data management and biostatistics firm

  Fort Lauderdale, FL, April 11, 2016 - OmniComm Systems, Inc., a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm’s TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations.   “We are pleased that OmniComm Systems is realizing the value of the Israeli market and the position of Medistat as a global provider of data management and biostatistician solutions,” said Dr. Gil Harari President and CEO of Medistat, “We truly believe that the cooperation with OmniComm will be a key factor to becoming a leader in the rapidly growing Intelligent EDC market in Israel and worldwide.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.